1. Marrouche N, Grattan C. Childhood urticaria. Curr Opin Allergy Clin Immunol. 2012; 12:485–490. PMID:
22825024.
Article
2. Fiebiger E, Hammerschmid F, Stingl G, Maurer D. Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship. J Clin Invest. 1998; 101:243–251. PMID:
9421487.
Article
3. Irinyi B, Széles G, Gyimesi E, Tumpek J, Herédi E, Dimitrios G, et al. Clinical and laboratory examinations in the subgroups of chronic urticaria. Int Arch Allergy Immunol. 2007; 144:217–225. PMID:
17579280.
Article
4. Ebo DG, Bridts CH, Hagendorens MM, Aerts NE, De Clerck LS, Stevens WJ. Basophil activation test by flow cytometry: present and future applications in allergology. Cytometry B Clin Cytom. 2008; 74:201–210. PMID:
18412216.
Article
5. Marone G, Spadaro G, Patella V, Genovese A. The clinical relevance of basophil releasability. J Allergy Clin Immunol. 1994; 94:1293–1303. PMID:
7528235.
Article
6. Zuberbier T, Schwarz S, Hartmann K, Pfrommer C, Czarnetzki BM. Histamine releasability of basophils and skin mast cells in chronic urticaria. Allergy. 1996; 51:24–28. PMID:
8721524.
Article
7. Szegedi A, Irinyi B, Gál M, Hunyadi J, Dankó K, Kiss E, et al. Significant correlation between the CD63 assay and the histamine release assay in chronic urticaria. Br J Dermatol. 2006; 155:67–75. PMID:
16792754.
Article
8. Sabroe RA, Grattan CE, Francis DM, Barr RM, Kobza Black A, Greaves MW. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol. 1999; 140:446–452. PMID:
10233264.
Article
9. Frezzolini A, Provini A, Teofoli P, Pomponi D, De Pità O. Serum-induced basophil CD63 expression by means of a tricolour flow cytometric method for the in vitro diagnosis of chronic urticaria. Allergy. 2006; 61:1071–1077. PMID:
16918509.
Article
10. Gyimesi E, Sipka S, Dankó K, Kiss E, Hidvégi B, Gál M, et al. Basophil CD63 expression assay on highly sensitized atopic donor leucocytes-a useful method in chronic autoimmune urticaria. Br J Dermatol. 2004; 151:388–396. PMID:
15327546.
Article
11. Ocmant A, Peignois Y, Mulier S, Hanssens L, Michils A, Schandené L. Flow cytometry for basophil activation markers: the measurement of CD203c up-regulation is as reliable as CD63 expression in the diagnosis of cat allergy. J Immunol Methods. 2007; 320:40–48. PMID:
17275019.
Article
12. Cozon G, Ferrándiz J, Peyramond D, Brunet J. Detection of activated basophils using flow cytometry for diagnosis in atopic patients. Allergol Immunopathol (Madr). 1999; 27:182–187. PMID:
10486441.
13. Ebo DG, Lechkar B, Schuerwegh AJ, Bridts CH, De Clerck LS, Stevens WJ. Comments regarding 'Marked improvement of the basophil activation test by detecting CD203c instead of CD63' by Boumiza et al. Clin Exp Allergy. 2003; 33:849. author reply 852-3. PMID:
12801323.
14. Gentinetta T, Pecaric-Petkovic T, Wan D, Falcone FH, Dahinden CA, Pichler WJ, et al. Individual IL-3 priming is crucial for consistent in vitro activation of donor basophils in patients with chronic urticaria. J Allergy Clin Immunol. 2011; 128:1227–1234.e5. PMID:
21855127.
15. Marone G, Giugliano R, Lembo G, Ayala F. Human basophil releasability. II. Changes in basophil releasability in patients with atopic dermatitis. J Invest Dermatol. 1986; 87:19–23. PMID:
2425005.
Article
16. Sturm EM, Kranzelbinder B, Heinemann A, Groselj-Strele A, Aberer W, Sturm GJ. CD203c-based basophil activation test in allergy diagnosis: characteristics and differences to CD63 upregulation. Cytometry B Clin Cytom. 2010; 78:308–318. PMID:
20533392.
Article
17. Wedi B, Novacovic V, Koerner M, Kapp A. Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression--inhibitory effects of anti-inflammatory drugs. J Allergy Clin Immunol. 2000; 105:552–560. PMID:
10719307.
Article
18. Chirumbolo S. The use of IL-3 in basophil activation tests is the real pitfall. Cytometry B Clin Cytom. 2011; 80:137–138. author reply 139PMID:
20845369.
Article
19. Hausmann OV, Gentinetta T, Fux M, Ducrest S, Pichler WJ, Dahinden CA. Robust expression of CCR3 as a single basophil selection marker in flow cytometry. Allergy. 2011; 66:85–91. PMID:
20608915.
Article
20. Ducrest S, Meier F, Tschopp C, Pavlovic R, Dahinden CA. Flowcytometric analysis of basophil counts in human blood and inaccuracy of hematology analyzers. Allergy. 2005; 60:1446–1450. PMID:
16197480.
Article
21. Chirumbolo S, Ortolani R, Vella A. CCR3 as a single selection marker compared to CD123/HLADR to isolate basophils in flow cytometry: some comments. Cytometry A. 2011; 79:102–106. PMID:
21265004.
Article
22. Ferrer M, Luquin E, Sanchez-Ibarrola A, Moreno C, Sanz ML, Kaplan AP. Secretion of cytokines, histamine and leukotrienes in chronic urticaria. Int Arch Allergy Immunol. 2002; 129:254–260. PMID:
12444324.
Article
23. Hennersdorf F, Florian S, Jakob A, Baumgärtner K, Sonneck K, Nordheim A, et al. Identification of CD13, CD107a, and CD164 as novel basophil-activation markers and dissection of two response patterns in time kinetics of IgE-dependent upregulation. Cell Res. 2005; 15:325–335. PMID:
15916720.
Article
24. Yasnowsky KM, Dreskin SC, Efaw B, Schoen D, Vedanthan PK, Alam R, et al. Chronic urticaria sera increase basophil CD203c expression. J Allergy Clin Immunol. 2006; 117:1430–1434. PMID:
16751009.
Article
25. Laidlaw TM, Steinke JW, Tiñana AM, Feng C, Xing W, Lam BK, et al. Characterization of a novel human mast cell line that responds to stem cell factor and expresses functional FcεRI. J Allergy Clin Immunol. 2011; 127:815–822.e1-5. PMID:
21281958.
Article
26. Rashid A, Sadroddiny E, Ye HT, Vratimos A, Sabban S, Carey E, et al. Review: diagnostic and therapeutic applications of rat basophilic leukemia cells. Mol Immunol. 2012; 52:224–228. PMID:
22750069.
Article